Journal of Oncology Research and Treatment
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentary   
  • J Oncol Res Treat,
  • DOI: 10.4172/aot.s3.1000001

Telemedicine as a Therapeutic Option in Gynecologic Cancer Care Management due COVID-19 Pandemics: Cross-Sectional Study among Physicians and Patients

Stefan Hertling1,2*, Franziska Maria Loos3, Doreen Hertling4 and Isabel Graul5
1Department of Obstetrics and Gynecology, University Hospital Jena, Gujarat University, Jena, Germany
2Orthopaedic Department, Campus Eisenberg, University Hospital Jena, Jena, Germany
3Department of Orthopedics and Shoulder Surgery, Leipzig, Germany
4Department of Gynecology, Hospital Rummelsberg, University Hospital Erlangen, Erlangen, Germany
5Department of Trauma, Hand and Reconstructive Surgery, University of Jena, Jena, Germany
*Corresponding Author : Stefan Hertling, Department of Obstetrics and Gynecology, University Hospital Jena, Am Klinikum 1, 07747 Jena, Germany, Email: stefan.hertling@yahoo.de

Received Date: Jul 03, 2021 / Accepted Date: Jul 17, 2021 / Published Date: Jul 24, 2021

Abstract

Background: The global incidence in the treatment of people with cancer is increasing. In the COVID-19 pandemic, many consultations had to be cancelled, postponed or converted to a virtual format. Telemedicine serves as a treatment option in other medical disciplines. This study analyses the use and perception of telemedicine as a therapeutic option in gynecologic cancer care management in Germany.

Methods: This prospective cross-sectional study was based on a survey of gynecological oncologists and patients in Germany during the COVID-19 pandemic. Descriptive statistics were calculated. Regression analyses were performed to show correlations.

Results: We analyzed the responses of 529 patients and 402 gynecological oncologists. Most believed that telemedicine is useful. Physicians as well as patients rated their knowledge of telemedicine as unsatisfactory. The majority of respondents said they do not currently use telemedicine, although would like to do so. Patients and physicians reported that their attitude had changed positively towards telemedicine and that their usage had increased due to COVID-19. The majority in both groups agreed on implementing virtual visits in stable disease conditions.

Conclusion: Telemedicine as a therapeutic option in gynecologic cancer care management finds limited use but high acceptance among physicians and patients alike.

Keywords: Health; Telemedicine; Health services research; COVID-19; Gynecological oncology

Citation: Hertling S, Loos FM, Hertling D, Graul I (2021) Telemedicine as a Therapeutic Option in Gynecologic Cancer Care Management due COVID-19 Pandemics: Cross-Sectional Study among Physicians and Patients. J Oncol Res Treat S3:001. Doi: 10.4172/aot.s3.1000001

Copyright: © 2021 Hertling S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top